Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581204 · ClinicalTrials.gov registry record
Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans
A clinical trial of Hemorrhagic Shock, sponsored by University of California, Irvine.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT00581204: Completed study of Hemorrhagic Shock, sponsored by University of California, Irvine.
NCT00581204 is a study of Hemorrhagic Shock that has completed, run by University of California, Irvine. The registered enrollment target is 8 participants, below the 687-participant average among 3 other Hemorrhagic Shock trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581204, a study of Hemorrhagic Shock, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose for this study is to measure the physiology of human undergoing a Lower Body Negative Pressure usea non-invasive low-power optical technique, near-infrared diffuse optical spectroscopy measurement and compare these measurement to standard monitoring procedures delineated in the Brooke Army Medical Center. The Brooke Army Medical Center can use near-infrared diffuse optical spectroscopy to provide functional physiologic tissue and organ information without ionizing radiation and without withdrawing any blood, in a cost-effective and rapid manner. Monitoring for the onset of circulatory shock in a wounded soldier on the battlefield is typically performed by measurement of arterial blood pressure, arterial oxygen saturation, or simple auscultation of the pulse. Shock is typically recognized by non-specific signs and subjective symptoms such as cold clammy skin, pallor, weak thready pulse, unstable vital signs, and diminished mentation.
Primary Outcome
The near-infrared diffuse optical spectroscopy measure tissues properties
Conditions Studied
Interventions
- DEVICE Near-Infrared Diffuse Optical Spectroscopy
Study Locations (1)
California
- Beckman Laser Institute,University of California, Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-12 |
| Est. Completion | 2011-12 |
What the finished NCT00581204 record still lists
NCT00581204 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 687-participant average among 3 other Hemorrhagic Shock trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hemorrhagic Shock appearing as the primary indexed condition, and to 1 intervention - of which Near-Infrared Diffuse Optical Spectroscopy is the first listed.
NCT00581204 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00581204 about?
NCT00581204 is a clinical study titled "Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans". The purpose for this study is to measure the physiology of human undergoing a Lower Body Negative Pressure usea non-invasive low-power optical technique, near-infrared diffuse optical spectroscopy measurement and compare these measurement to standard monitoring procedures delineated in the Brooke Ar...
What is the current status of trial NCT00581204?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2011-12. Estimated completion is 2011-12.
What conditions does trial NCT00581204 study?
This clinical trial studies the following conditions: Hemorrhagic Shock.
What interventions are being tested in trial NCT00581204?
The interventions under investigation include: Near-Infrared Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00581204?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00581204 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemorrhagic Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia